Fidelity® Select Pharmaceuticals Portfolio (FPHAX)

23.87
Net Asset Value
-0.21%
1 Day
+11.65%
Year-to-Date
Overall Morningstar Rating
Health
Style or Category
No Load
Sales Expenses
0.79%
Expense Ratio
Below Average
Morningstar Risk Rating™
Investment Objective The investment seeks capital appreciation. The fund normally invests at least 80% of assets in companies engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and drugs of all types. It invests in domestic and foreign issuers. The fund invests primarily in common stocks. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions to select investments. The fund is non-diversified.

Performance

1 month-0.25% 3 years+28.43%
3 months+5.28% 5 years+26.21%
1 year+23.00% Since inception+10.02%
Data through --

Peer Comparisonvs. Health

 FPHAXCategory
Performance 5-yr return+26.21%+26.59%
Expense ratio0.79%1.42%
Risk 5 year sharpe ratio2.151.82
Net assets$2.2B$4.1B
Average market cap$62.8B$38.6B
Average P/E25.524.7
Portfolio turnover72%72%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyFidelity Investments
Fund manager & tenureAsher Anolic / 2 Years
Minimal initial investment$2,500.00
Minimum IRA investment$2,500.00

Holdings

U.S. stock56.70%
International stock42.16%
Cash1.12%
Other0.01%
Fixed income0.00%
Top 5 Sectors
Portfolio weighting
Healthcare 98.48%
Hardware 0.61%
Consumer goods 0.39%
Business service 0.00%
Consumer service 0.00%
Top 10 Holdings
Portfolio weighting
JNJ Johnson & Johnson11.45%
AGN Allergan9.39%
SNY Sanofi6.92%
ABBV AbbVie6.73%
BMY Bristol-Myers Squibb5.28%
NVS Novartis4.54%
NVO Novo Nordisk4.46%
TEVA Teva Pharmaceutical3.66%
MYL Mylan NV3.05%
LLY Eli Lilly and Co3.04%

To view my watchlist

Not a member yet?

Sign up now for a free account